EP1889607A1 — Injectable liquid paracetamol formulation
Assigned to Genfarma Laboratorio SL · Expires 2008-02-20 · 18y expired
What this patent protects
The invention relates to an aqueous paracetamol solution for its use by perfusion with a pH between 4.5 and 6.0, comprising at least one stabilizing substance of paracetamol in solution such as glucose, fructose, gluconate, sodium formaldehyde sulfoxylate, sodium sulfite or sodiu…
USPTO Abstract
The invention relates to an aqueous paracetamol solution for its use by perfusion with a pH between 4.5 and 6.0, comprising at least one stabilizing substance of paracetamol in solution such as glucose, fructose, gluconate, sodium formaldehyde sulfoxylate, sodium sulfite or sodium dithionite in a suitable concentration, able to stabilize the paracetamol in the presence of oxygen. The injectable paracetamol solution of the present invention has high stability, does not develop color over time and has a minimal content of impurities when the amount of these stabilizing substances is adjusted to specific values.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.